Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Burkitt Lymphoma 7Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Biphenotypic, Acute 2Leukemia 2Down Syndrome 2Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Lymphoma 1

Interventions

Cyclophosphamide 22Dexamethasone 15Cytarabine 14venetoclax 13Vincristine 13Methotrexate 10Etoposide 10Prednisone 9Doxorubicin 9Calcium Dobesilate 9prednylidene 8dexamethasone acetate 8dexamethasone 21-phosphate 8deltacortene 8auricularum 8merphos 7Specimen Handling 7pegaspargase 6fludarabine phosphate 6daratumumab 6calaspargase pegol 6Mercaptopurine 6Granulocyte Colony-Stimulating Factor 6fludarabine 5Stem Cell Transplantation 5Filgrastim 5Daunorubicin 5Bortezomib 5Biopsy 5Asparaginase 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × asparaginase erwinia chrysanthemi recombinant × 1 year × Clear all
NCT06738368 2026-05-12

Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

University of Washington

Phase 2 Recruiting
30 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡